glp-1 kidney disease news agonists in the treatment of chronic in type 2 diabetes and obesity Unlocking Cardio-Renal Protection: Breakthrough with

My GP has prescribed Mounjaro and I've had right-sided pain

Lovshin JA, Drucker DJ

doi: 10.1016/j.celrep.2017.11.036 267 SymondsE

Regulatory treatment of GLP-1 support foods varies significantly between markets, creating complexity for companies operating internationally: EU/UK Explicit references to GLP-1 are not permitted, and weight management claims remain tightly controlled within specific regulated categories such as meal replacements Japan/Brazil Limited GLP-1 claims may be possible via specialist/health channels

Implementing targeted controls on GLP-1 coverage

Accordingly, recent systematic reviews have provided substantial reassurance regarding the psychiatric safety profile of GLP-1RAs